These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7948385)

  • 21. Reduced expression of calponin in canine basilar artery after subarachnoid haemorrhage.
    Doi M; Kasuya H; Weir B; Cook DA; Ogawa A
    Acta Neurochir (Wien); 1997; 139(1):77-81. PubMed ID: 9059716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of basilar artery diameter in dogs: CT evaluation correlated with arteriography.
    Ho PS; Lee CC; Wang JY; Wang YC; Lin SZ; Chen FH; Chen JL
    Neuroradiology; 1988; 30(3):239-44. PubMed ID: 3405412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebral posthemorrhagic vasospasm. A sequential in vivo and in vitro study of the basilar artery of the rabbit].
    Vorkapic P
    Zentralbl Neurochir; 1990; 51(1):1-17. PubMed ID: 2275298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626).
    Alksne JF; Branson PJ
    Stroke; 1979; 10(6):638-44. PubMed ID: 118551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T; Wakai S; Asano T; Takakura K; Sano K
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chlorpromazine on experimental delayed cerebral vasospasm.
    Nakano M; Tani E; Fukumori T; Yokota M
    J Neurosurg; 1984 Nov; 61(5):857-63. PubMed ID: 6491731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental catecholamine-induced chronic cerebral vasospasm. Myonecrosis in vessel wall.
    Alksne JF; Greenhoot JH
    J Neurosurg; 1974 Oct; 41(4):440-5. PubMed ID: 4213103
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental model of symptomatic vasospasm in rabbits.
    Endo S; Branson PJ; Alksne JF
    Stroke; 1988 Nov; 19(11):1420-5. PubMed ID: 3188126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional analysis of vasospastic major cerebral arteries in rats with the corrosion cast technique.
    Ono S; Date I; Nakajima M; Onoda K; Ogihara K; Shiota T; Asari S; Ninomiya Y; Yabuno N; Ohmoto T
    Stroke; 1997 Aug; 28(8):1631-7; discussion 1638. PubMed ID: 9259761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of intrathecal liposomal fasudil for experimental cerebral vasospasm after subarachnoid hemorrhage.
    Takanashi Y; Ishida T; Meguro T; Kiwada H; Zhang JH; Yamamoto I
    Neurosurgery; 2001 Apr; 48(4):894-900; discussion 900-1. PubMed ID: 11322450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral vasospasm model produced by subarachnoid blood injection in dogs.
    Saito A; Nakazawa T
    Jpn J Pharmacol; 1989 Jun; 50(2):250-2. PubMed ID: 2770061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral vasospasm and vasoconstriction caused by endothelin.
    Kobayashi H; Hayashi M; Kobayashi S; Kabuto M; Handa Y; Kawano H; Ide H
    Neurosurgery; 1991 May; 28(5):673-8; discussion 678-9. PubMed ID: 1876245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm.
    Matsui T; Takuwa Y; Johshita H; Yamashita K; Asano T
    J Cereb Blood Flow Metab; 1991 Jan; 11(1):143-9. PubMed ID: 1983998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of chronic cerebral vasospasm in dogs with milrinone.
    Khajavi K; Ayzman I; Shearer D; Jones SC; Levy JH; Prayson RA; Skibinski CI; Hahn JF; Chyatte D
    Neurosurgery; 1997 Feb; 40(2):354-62; discussion 362-3. PubMed ID: 9007870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiographic evidence of basilar artery constriction in the rabbit: a new model of vasospasm.
    Baker KF; Zervas NT; Pile-Spellman J; Vacanti FX; Miller D
    Surg Neurol; 1987 Feb; 27(2):107-12. PubMed ID: 3810438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of endothelin in experimental cerebral vasospasm.
    Roux S; Löffler BM; Gray GA; Sprecher U; Clozel M; Clozel JP
    Neurosurgery; 1995 Jul; 37(1):78-85; discussion 85-6. PubMed ID: 8587695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental cerebral vasospasm induced by oxyhemoglobin and the sympathetic nervous system (Part 2): An investigation into denervation supersensitivity].
    Iwai R; Endo S; Kamiyama K; Otsuji T; Sugita T; Takaku A
    No To Shinkei; 1988 Jul; 40(7):603-8. PubMed ID: 3146988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cerebral vasospasm and vasoactive amines (author's transl)].
    Kuwayama A
    No Shinkei Geka; 1975 Dec; 3(12):1001-7. PubMed ID: 1241109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid peroxidation as a cause of cerebral vasospasm.
    Sano K; Asano T; Tanishima T; Sasaki T
    Neurol Res; 1980; 2(3-4):253-72. PubMed ID: 6111034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.